Pfizer raises 2026 guidance after Q3, reports pipeline progress and new CFONov 3Quarterly updateBioNTech SEC4 Therapeutics, Inc.
Iovance registers two new trials: IOV-5001 solid tumor study and lifileucel sarcoma trialAug 4Weekly roundup, 2 itemsIOV-5001Iovance Biotherapeutics, Inc.